Laboratory Products
Complete Range of Automated Tests for Osteoporosis
Sep 09 2009
Roche Diagnostics offers one of the most complete ranges of tests for osteoporosis that can be performed on a single serum work area platform. As concerns are raised about the limited use of more expensive
treatments for osteoporosis1, this comprehensive range of Elecsys® bone marker assays provides valuable information for the diagnostic and prognostic assessment of bone metabolism in patients with, or at risk of,
osteoporosis and other bone diseases, in addition to providing an early indication of response and adherence to treatment.
According to the National Osteoporosis Society, one in two women and one in five men over the age of 50 will suffer a bone fracture, the main cause of which is osteoporosis. Among the most commonly used treatments for osteoporosis are the bisphosphonates. Although this group of drugs can be highly effective, gastric side effects and a complex treatment regimen can result in poor adherence. Alternative treatments, such as anabolic therapies, are more expensive, and so are less likely to be prescribed as a first choice.
The traditional method for measuring response to treatment, bone mass densitometry (BMD), can take up to two years to demonstrate improvement to bone density. The availability of the Roche Elecsys® range of bone marker, hormone and bone mineral assays on a single serum work area allows response to treatment and patient compliance to be monitored at an earlier stage (as early as 3-6 months after initiation of treatment) and
throughout the course of treatment, encouraging adherence to treatment and providing medical staff with valuable information about the effectiveness of the treatment in use. The comprehensive range of osteoporosis tests available from Roche for use with cobas® or MODULAR Analytics serum work areas include the Elecsys® bone marker assays (ß-CrossLaps, total PINP, N-Mid Osteocalcin and vitamin D3-OH), the Elecsys® hormone assays (parathormone, oestradiol, testosterone, DHEA and SHBG) and bone mineral assays (calcium and phosphate).
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK